tech
Novo Owner Backs Italy Fund to Spur Drug Startups Beyond Denmark
Novo Nordisk A/S’s biggest shareholder is investing in a new Italian startup accelerator, part of an effort to foster early stage life science companies across Europe.
Read full story on Bloomberg Tech → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Tech alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop